Cause-specific mortality among patients with Hodgkin lymphoma (HL) up to 40 years after treatment.

Author:

Schaapveld Michael1,van Eggermond Anna M.2,Janus Cecile P.M.3,Krol Augustinus D.G.4,Raemaekers John M. M.5,Clevers-Petersen Eefke J.6,Lugtenburg Pieternella J.7,Zijlstra Jose M.8,Van Imhoff Gustaaf Willem9,Van Der Maazen Richard W.M.10,Roesink Judith M.11,Beijert Max L.12,Poortmans Philip M.13,Kremer Leontien C.M.14,Louwman Marieke J.15,Lybeert Marnix16,De Boer J. P.2,Aleman Berthe M.P.17,van Leeuwen Flora E.1

Affiliation:

1. Department of Psychosocial Oncology and Epidemiology,The Netherlands Cancer Institute, Amsterdam, Netherlands

2. Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

3. Erasmus Medical Center Cancer Institute, Department of Radiation Oncology, Rotterdam, Netherlands

4. Leiden University Medical Center, Department of Clinical Oncology, Leiden, Netherlands

5. Department of Internal Medicine, Hematology, Radboud University Medical Center, Nijmegen, Netherlands

6. Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands

7. Department of Hematology, Erasmus Medical Center Cancer Insitute, Rotterdam, Netherlands

8. Department of Hematology, VU University Medical Center, Amsterdam, Netherlands

9. Department of Hematology, University Medical Center Groningen, Groningen, Netherlands

10. Department of Radiotherapy, Radboud University Medical Center, Nijmegen, Netherlands

11. Department of Radiotherapy, University Medical Center Utrecht, Utrecht, Netherlands

12. Department of Radiotherapy, University Medical Center Groningen, Groningen, Netherlands

13. Institute Verbeeten, Tilburg, Netherlands

14. Department of Pediatric Oncology, Emma Children’s Hospital/Academic Medical Center, Amsterdam, Netherlands

15. Comprehensive Cancer Centre South Netherlands, Eindhoven, Netherlands

16. Department of Radiotherapy, Catharina Hospital, Eindhoven, Netherlands

17. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3